skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Probing Multidrug-Resistance and Protein-Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors

Journal Article · · ChemMedChem(Print)
 [1];  [1];  [1];  [1];  [2];  [2];  [2];  [3];  [3];  [3];  [4]
  1. Purdue Univ., West Lafayette, IN (United States)
  2. Georgia State Univ., Atlanta, GA (United States)
  3. Kumamoto Univ. School of Medicine (Japan)
  4. Kumamoto Univ. School of Medicine (Japan); National Cancer Inst., Bethesda, MD (United States)

We report the design, synthesis, biological evaluation, and X-ray crystallographic analysis of a new class of HIV-1 protease inhibitors. Compound 4 proved to be an extremely potent inhibitor toward various multidrug-resistant HIV-1 variants, representing a near 10-fold improvement over darunavir (DRV). Compound 4 also blocked protease dimerization with at least 10-fold greater potency than DRV.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
USDOE
OSTI ID:
1002836
Journal Information:
ChemMedChem(Print), Vol. 5, Issue (11) ; 11, 2010; ISSN 1860-7179
Publisher:
ChemPubSoc Europe
Country of Publication:
United States
Language:
ENGLISH